Ticker Details
Nuvalent, Inc.
IPO Date:	July 29, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.99B
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$1.40 | 3.01%
Avg Daily Range (30 D):	$2.46 | 2.41%
Avg Daily Range (90 D):	$1.92 | 1.87%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	.61M
Avg Daily Volume (90 D):	.5M

Trade Size
Avg Trade Size (Sh.):	48
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	48

Institutional Trades
Total Institutional Trades:	21
Avg Institutional Trade:	$13.95M
Avg Institutional Trade (30 D):	$13.95M
Avg Institutional Trade (90 D):	$13.95M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	21

Market Closing Trades
Avg Closing Trade:	$41.35M
Avg Closing Trade (30 D):	$41.35M
Avg Closing Trade (90 D):	$41.35M
Avg Closing Volume:	335.24K

News

Jun 30, 2026 @ 6:50 PM Halper Sadeh LLC is Investigating Whether LCII, NU... Source: Halper Sadeh Llc

Jun 22, 2026 @ 5:43 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Jun 18, 2026 @ 10:10 PM The M&A Class Action Firm Encourages $hareholders ... Source: Juan Monteverde, Monteverde & Associates Pc

Jun 17, 2026 @ 1:14 AM Halper Sadeh LLC is Investigating Whether LPRO, NU... Source: Halper Sadeh Llc

Jun 11, 2026 @ 5:18 PM Patent Cliff Predators: GSK Acquires Nuvalent For ... Source: Jeffrey Neal Johnson

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-6.06	$-1.39	$-1.58
Diluted EPS	$-6.06	$-1.39	$-1.58
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-450.07M	$-109.28M	$-118.71M
Operating Income / Loss	$-438.9M	$-119.41M	$-102.23M
Cost of Revenue
Net Cash Flow	$38.9M	$-102.01M	$145.99M
PE Ratio